Managed care
Rachel C. Vurbeff PNP Childrens Day/Night Clinic
Rachel C. Vurbeff PNP Childrens Day/Night Clinic was paid $838K by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoRACHEL C. VURBEFF PNP CHILDRENS DAY/NIGHT CLINIC
LAREDO, TX 78043
LAREDO, TX 78043
33aNPI1952617797assigned 08/30/2010
33bProvider typePreferred Provider Organization
28Total paid$838K
24GClaims85,796
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Preferred Provider Organization providers in Texas
Rank by total paid#9 of 32
Median peer was paid$168K
This provider vs. median5.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 130 | $3K | |
| 2019 | 132 | $3K | |
| 2020 | 2,934 | $51K | |
| 2021 | 14,596 | $187K | |
| 2022 | 18,975 | $232K | |
| 2023 | 23,261 | $191K | |
| 2024incomplete | 25,768 | $170K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 23,456 | 16,230 | $235K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 17% | 1,986 | 1,905 | $141K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 13% | 1,427 | 1,366 | $108K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 1,549 | 1,466 | $100K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.2% | 5,534 | 2,424 | $52K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 746 | 713 | $48K |
| 99050 | 4.5% | 3,264 | 2,769 | $37K | |
| 99051 | 3.1% | 7,713 | 6,048 | $26K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.1% | 4,217 | 3,727 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 320 | 306 | $13K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 1,981 | 1,590 | $13K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.3% | 602 | 572 | $11K |
33 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,124 | $7K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 70 | $5K |
| 99000 | <1% | 1,951 | $3K | |
| 96160 | <1% | 8,114 | $3K | |
| 90461 | <1% | 1,401 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 381 | $1K |
| 99429 | <1% | 38 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 303 | $875.09 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 311 | $848.27 |
| 99383 | <1% | 14 | $762.48 | |
| 86580 | <1% | 200 | $674.36 | |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | <1% | 7,110 | $497.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 985 | $439.71 |
| 96161 | <1% | 6,692 | $136.71 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 199 | $115.90 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 194 | $67.55 |
| 90620 | <1% | 64 | $0.02 | |
| 90651 | <1% | 356 | $0.01 | |
| 90715 | <1% | 83 | $0.01 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 407 | $0.00 |
| 90723 | 0% | 12 | $0.00 | |
| 90680 | 0% | 25 | $0.00 | |
| 90696 | 0% | 32 | $0.00 | |
| 90697 | 0% | 43 | $0.00 | |
| 90686 | 0% | 36 | $0.00 | |
| 90716 | 0% | 20 | $0.00 | |
| 90671 | 0% | 147 | $0.00 | |
| 90633 | 0% | 167 | $0.00 | |
| 90670 | 0% | 237 | $0.00 | |
| 90710 | 0% | 71 | $0.00 | |
| 90734 | 0% | 151 | $0.00 | |
| 90648 | 0% | 45 | $0.00 | |
| 90707 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVURBEFF, RACHEL (PRESIDENT)